Literature DB >> 3083240

Polymorphism in a kappa I primary (AL) amyloid protein (BAN).

F E Dwulet, T P O'Connor, M D Benson.   

Abstract

In an attempt to understand the relationship of amino acid sequence to the formation of primary or multiple myeloma-related amyloid (AL amyloid), we have determined the complete amino acid sequence of amyloid protein BAN. This protein belongs to the kappa I immunoglobulin light chain subgroup and has a polypeptide chain length of 126 amino acids. It encompasses the entire variable region, the joining segment and the first tryptic peptide of the constant region. This protein has two unique features. First, the molecule is glycosylated. At position 61 the usual arginine residue has been replaced by an asparagine with the generation of the signal sequence Asn-Phe-Thr, to which a glucosamine-containing carbohydrate unit is attached. Secondly, the protein is not monoclonal but consists of two chains which have the same variable region but different J-segments. Comparison of the BAN sequence with other amyloid and nonamyloid kappa I proteins reveals a systematic difference between the two groups. In the amyloid proteins, several hydrophilic framework residues have been replaced by hydrophobic residues. These substitutions may provide the nucleation sites for self-aggregation and fibril formation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083240     DOI: 10.1016/0161-5890(86)90173-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).

Authors:  Roshini S Abraham; Susan M Geyer; Marina Ramírez-Alvarado; Tammy L Price-Troska; Morie A Gertz; Rafael Fonseca
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

2.  Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains.

Authors:  Lawreen H Connors; Yan Jiang; Marianna Budnik; Roger Théberge; Tatiana Prokaeva; Kip L Bodi; David C Seldin; Catherine E Costello; Martha Skinner
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

3.  Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization.

Authors:  M M Picken; B Frangione; B Barlogie; M Luna; G Gallo
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

4.  The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL).

Authors:  E M Fykse; K Sletten; G Husby; G G Cornwell
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

5.  A role for destabilizing amino acid replacements in light-chain amyloidosis.

Authors:  M R Hurle; L R Helms; L Li; W Chan; R Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

6.  An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.

Authors:  Alice Nevone; Maria Girelli; Silvia Mangiacavalli; Bruno Paiva; Paolo Milani; Pasquale Cascino; Maggie Piscitelli; Valentina Speranzini; Claudio Salvatore Cartia; Pietro Benvenuti; Ibai Goicoechea; Francesca Fazio; Marco Basset; Andrea Foli; Martina Nanci; Giulia Mazzini; Serena Caminito; Melania Antonietta Sesta; Simona Casarini; Paola Rognoni; Francesca Lavatelli; Maria Teresa Petrucci; Pier Paolo Olimpieri; Stefano Ricagno; Luca Arcaini; Giampaolo Merlini; Giovanni Palladini; Mario Nuvolone
Journal:  Leukemia       Date:  2022-05-24       Impact factor: 12.883

7.  Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.

Authors:  G Gallo; F Goñi; F Boctor; R Vidal; A Kumar; F J Stevens; B Frangione; J Ghiso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

8.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

9.  Complementary DNA sequence of human amyloidogenic immunoglobulin light-chain precursors.

Authors:  P Aucouturier; A A Khamlichi; J L Preud'homme; M Bauwens; G Touchard; M Cogné
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.